You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iNO

Showing 1 - 25 of 255
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))

Completed
  • Healthy Volunteers
  • INO-A002
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 7, 2022

Lassa Fever Trial in Legon (INO-4500, CELLECTRA™ 2000, Placebo)

Completed
  • Lassa Fever
  • Legon, Accra, Ghana
    Noguchi Memorial Institute for Medical Research, University of G
Nov 18, 2022

Coronavirus Infection Trial (INO-4800, INO-9112, CELLECTRA® 2000)

Not yet recruiting
  • Coronavirus Infection
  • (no location specified)
Jun 21, 2022

Infective Complications and Outcome of ALL Treated With INO

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
    • (no location specified)
    Aug 29, 2023

    Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Jordan, Kenya, Lebanon (INO-4700, Placebo, CELLECTRA™ 2000)

    Completed
    • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    • Irbid, Jordan
    • +5 more
    Jan 27, 2023

    Pulmonary Embolism, Pulmonary Embolism Subacute Massive Trial in Los Angeles (inhaled nitric oxide (iNO))

    Withdrawn
    • Pulmonary Embolism
    • Pulmonary Embolism Subacute Massive
    • inhaled nitric oxide (iNO)
    • Los Angeles, California
      Ronald Reagan UCLA Medical Center
    May 11, 2022

    HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

    Recruiting
    • HIV-1-infection
    • INO-6160, 2 mg
    • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
    • New York, New York
    • +2 more
    Apr 13, 2023

    Inhaled Nitric Oxide Responsiveness in Patients With PPHN

    Withdrawn
    • PPHN
    • Hypoxic Respiratory Failure
      • (no location specified)
      Sep 12, 2023

      Coronavirus Infection, SARS-CoV 2 Trial in Seongnam-si, Seoul (biological, device, other)

      Completed
      • Coronavirus Infection
      • SARS-CoV 2
      • INO-4800
      • +2 more
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
      • +1 more
      Jul 14, 2022

      Coronavirus Infection, COVID-19, Pneumonia, Viral Trial (iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System)

      No longer available
      • Coronavirus Infection
      • +2 more
      • iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System
      • (no location specified)
      Aug 9, 2022

      Glioblastoma Trial in United States (biological, radiation, drug)

      Active, not recruiting
      • Glioblastoma
      • INO-5401
      • +4 more
      • Duarte, California
      • +20 more
      Aug 8, 2022

      Dyspnea, Pulmonary Embolism Trial in Kingston (Nitric Oxide, Placebo)

      Recruiting
      • Dyspnea
      • Pulmonary Embolism
      • Nitric Oxide
      • Placebo
      • Kingston, Ontario, Canada
        Respiratory Investigation Unit, Kingston General Hospital
      Sep 8, 2022

      BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)

      Recruiting
      • BRCA1/2 Mutation
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 7, 2021

      ALL, MRD-positive, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Inotuzumab Ozogamicin)

      Recruiting
      • ALL
      • +2 more
      • Inotuzumab Ozogamicin
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jul 14, 2023

      Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

      Active, not recruiting
      • Chronic Hepatitis
      • Hepatitis C Infection
      • Electroporation-Mediated Plasmid DNA Vaccine Therapy
      • +4 more
      • Jacksonville, Florida
      • +4 more
      Sep 20, 2022

      Coronavirus Infection Trial in Lexington, Kansas City, Philadelphia (INO-4800, CELLECTRA® 2000)

      Completed
      • Coronavirus Infection
      • Lexington, Kentucky
      • +2 more
      Apr 13, 2022

      HCC Trial in Baltimore, New York, Auckland (biological, drug, device)

      Recruiting
      • HCC
      • GNOS-PV02
      • +3 more
      • Baltimore, Maryland
      • +2 more
      Apr 26, 2022

      Congenital Diaphragmatic Hernia Trial in Houston (Inhaled Nitric Oxide (iNO) use, De-implementation of Inhaled Nitric Oxide

      Not yet recruiting
      • Congenital Diaphragmatic Hernia
      • Inhaled Nitric Oxide (iNO) use
      • De-implementation of Inhaled Nitric Oxide (iNO) use
      • Houston, Texas
        The University of Texas Health Science Center at Houston
      Jan 27, 2022

      COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)

      Terminated
      • COPD
      • +2 more
      • Inhaled Nitric Oxide 30mcg/kg IBW/hr
      • Edegem, Belgium
        Antwerp University Hospital
      Aug 9, 2022

      Acute Respiratory Distress Syndrome, Ventilation Perfusion Mismatch Trial (Nitric Oxide)

      Not yet recruiting
      • Acute Respiratory Distress Syndrome
      • Ventilation Perfusion Mismatch
      • Nitric Oxide
      • (no location specified)
      Apr 12, 2023

      Cerebrovascular Disorders, Acute Cerebrovascular Disease Trial in Charlotte (iNO)

      Not yet recruiting
      • Cerebrovascular Disorders
      • Acute Cerebrovascular Disease
      • iNO
      • Charlotte, North Carolina
      • +1 more
      May 12, 2023

      Traumatic Brain Injury Trial in Philadelphia (inhaled nitric oxide)

      Not yet recruiting
      • Traumatic Brain Injury
      • inhaled nitric oxide
      • Philadelphia, Pennsylvania
        Penn Presbyterian Medical Center
      Nov 8, 2022

      Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

      Active, not recruiting
      • Human Papillomavirus-16 Positive
      • +20 more
      • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
      • Durvalumab
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 11, 2022

      Stroke Trial in Philadelphia (Nitric Oxide)

      Active, not recruiting
      • Stroke
      • Nitric Oxide
      • Philadelphia, Pennsylvania
        Hospital of the University of Pennsylvania
      Nov 23, 2022

      Cardiac Arrest Trial in Toronto (inhaled nitric oxide (iNO), Sham)

      Recruiting
      • Cardiac Arrest
      • inhaled nitric oxide (iNO)
      • Sham
      • Toronto, Ontario, Canada
      • +3 more
      May 11, 2023